MTRC released a seminar on reimbursement system for IVD tests in China

08

May 2020

China is a very complex market with mostly regional market access activities. 

At the national level, only the scope of covered services is determined. The detailed scope of services and detailed benefit catalogs are established at the level of local administrative units (provinces and cities). 

In out-patient settings, a fee for service model is used for reimbursement of services and in-vitro diagnostic tests. 

We offer a seminar on critical elements of the reimbursement system for IVD tests in China, that can guide your decision-making about the introduction of novel technologies into this market. The seminar discusses key stakeholders, money flow, reimbursement in ambulatory settings for IVD tests, national and regional Benefit Catalogs and the role of HTA for market access of IVD tests.

Learn more and get a quote here

The latest related news

22

Nov 2021

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

Read more

23

Sep 2021

In September 2021, MTRC received a certificate of conformity of the internal processes with the ISO 9001:2015 (quality management systems) standard. The certificate was issued by the United Kingdom Accreditation Service, UKAS. This confirms the commitment of the MTRC team to the provision of high-quality reimbursement services in Europe.

Read more

03

Aug 2021

A syndicated report (135 pages) reviews details of innovation funding and coverage with evidence development schemes in Europe, including Austria, Belgium, England, France, Germany, the Netherlands, and Switzerland. For each scheme, information about objective, inclusion criteria, applicant, stakeholders involved, clinical and economic evidence requirements, and statistics (including at least 2019-2020 data; but for most schemes – statistics for multiple years) is included.

Read more

12

Jul 2021

MTRC released an update of the syndicated report on reimbursement decisions for IVD tests in 5 EU countries (Belgium, France, Germany, the Netherlands, and Switzerland). The updated report covers 3-year period of 2018-2020. Broader coverage gives a better understanding of the activity of the reimbursement organizations.

Read more

17

May 2021

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

Read more